Page last updated: 2024-08-23
paclitaxel and pg 545
paclitaxel has been researched along with pg 545 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bampton, D; Block, MS; Chien, J; Dredge, K; Freyer, L; Giri, S; Hammond, E; Hoffmann, R; Millward, M; Mondal, S; Mullany, SA; Roy, D; Shridhar, V; Teoman, A; von Bismarck, A; Winterhoff, B | 1 |
Trials
1 trial(s) available for paclitaxel and pg 545
| Article | Year |
|---|---|
PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Synergism; Female; Humans; Mice; Mice, Inbred C57BL; Mice, SCID; Neoplasms; Ovarian Neoplasms; Paclitaxel; Saponins; Tumor Cells, Cultured; Up-Regulation; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2015 |